Search research articles
Contact Us
Filters
Showing results (1151-1160 of 1,203) with videos related to
Page
of 121
Sort By:
Plos One
|
April 5, 2013
The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study
Richard Hansen, Susan H Berry, Indrani Mukhopadhya, et al.
BMC Gastroenterology
|
December 4, 2021
Dietary triggers of gut inflammation following exclusive enteral nutrition in children with Crohn's disease: a pilot study
Konstantinos Gkikas, Michael Logan, Ben Nichols, et al.
Antiviral Therapy
|
February 19, 2014
Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate
Peter L Havens, Rohan Hazra, Charles B Stephensen, et al.
British Journal of Haematology
|
April 21, 2015
Jumping translocations, a novel finding in chronic lymphocytic leukaemia
Cecelia R Miller, Deborah Stephens, Amy S Ruppert, et al.
Mabs
|
July 26, 2013
Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies
Sarwish Rafiq, Anthony Siadak, Jonathan P Butchar, et al.
Antimicrobial Agents and Chemotherapy
|
September 8, 2011
Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants
Patricia M Flynn, Mark Mirochnick, David E Shapiro, et al.
Antimicrobial Agents and Chemotherapy
|
September 5, 2013
Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?
Peter L Havens, Jennifer J Kiser, Charles B Stephensen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial
Peter L Havens, Charles B Stephensen, Marta D Van Loan, et al.
American Journal of Hematology
|
July 24, 2015
Externally validated predictive clinical model for untreated del(17p13.1) chronic lymphocytic leukemia patients
Deborah M Stephens, Amy S Ruppert, William G Weirda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 26, 2016
Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis
Peter L Havens, Charles B Stephensen, Marta D Van Loan, et al.
Page
of 121
Search research articles
Search
Showing results (1151-1160 of 1,203) with videos related to
Sort By:
Page
of 121
Plos One
|
April 5, 2013
The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study
Richard Hansen, Susan H Berry, Indrani Mukhopadhya, et al.
BMC Gastroenterology
|
December 4, 2021
Dietary triggers of gut inflammation following exclusive enteral nutrition in children with Crohn's disease: a pilot study
Konstantinos Gkikas, Michael Logan, Ben Nichols, et al.
Antiviral Therapy
|
February 19, 2014
Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate
Peter L Havens, Rohan Hazra, Charles B Stephensen, et al.
British Journal of Haematology
|
April 21, 2015
Jumping translocations, a novel finding in chronic lymphocytic leukaemia
Cecelia R Miller, Deborah Stephens, Amy S Ruppert, et al.
Mabs
|
July 26, 2013
Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies
Sarwish Rafiq, Anthony Siadak, Jonathan P Butchar, et al.
Antimicrobial Agents and Chemotherapy
|
September 8, 2011
Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants
Patricia M Flynn, Mark Mirochnick, David E Shapiro, et al.
Antimicrobial Agents and Chemotherapy
|
September 5, 2013
Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?
Peter L Havens, Jennifer J Kiser, Charles B Stephensen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial
Peter L Havens, Charles B Stephensen, Marta D Van Loan, et al.
American Journal of Hematology
|
July 24, 2015
Externally validated predictive clinical model for untreated del(17p13.1) chronic lymphocytic leukemia patients
Deborah M Stephens, Amy S Ruppert, William G Weirda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 26, 2016
Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis
Peter L Havens, Charles B Stephensen, Marta D Van Loan, et al.
Page
of 121